BioSante Pharmaceuticals, Inc. to Present at Jefferies Global Healthcare Conference
Published on Monday, 04 June 2012 07:57 Written by TradersHuddle StaffLINCOLNSHIRE, Ill.-( Business Wire )-
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced that Stephen M. Simes, BioSante’s president & CEO will present a corporate update at the Jefferies 2012 Global Healthcare Conference in New York on June 6, 2012 at 11:00 am EDT.
Mr. Simes will provide an overview of BioSante, as well as an update on the LibiGel® (testosterone gel) Phase III clinical development program, and a review of published results using BioSante’s GVAX Cancer Immunotherapies in combination with ipilimumab (Ipi; Yervoy; BMS).
A live audio webcast of remarks by Mr. Simes may be accessed at http://wsw.com/webcast/jeff68/bpax/. The webcast will be archived for 90 days.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante´s products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD), which is in Phase III clinical development. BioSante also is developing a portfolio of cancer vaccines, with 17 Phase I and Phase II clinical trials currently on-going. Four of these vaccines have been granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA). BioSante´s other products include a testosterone gel for male hypogonadism, which is licensed to Teva Pharmaceuticals USA, Inc., and for which a New Drug Application (NDA) was approved by the FDA in February 2012, and the Pill-Plus™, an oral contraceptive in Phase II clinical development by Pantarhei Bioscience B.V. BioSante´s first FDA-approved product is Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, is marketed in the U.S. by Jazz Pharmaceuticals, BioSante´s licensee. Additional information is available online at: www.biosantepharma.com.
Related Partner Headlines
- Benzinga's M&A Chatter for Thursday October 4, 2012 - Benzinga
- BioSante Pharmaceuticals Closes $3.475M Direct Offering - Benzinga
- UPDATE: Jefferies Raises PT to $2 on BioSante Pharmaceuticals on LibiGel Phase III Trial Announcement - Benzinga
- BioSante Execs Use Failed Libigel To Keep Paychecks Rolling In - TheStreet.com
- Adam Feuerstein Publishes Negative Article on BioSante - Benzinga
- Orange County, CA: Housing Inventory Ghost Town - Benzinga
- BioSante Pharmaceuticals Announces New LibiGel Phase III Efficacy Trials - Benzinga
- Biosante Stock Gaps Down On Today's Open (BPAX) - TheStreet.com
- From Earlier: BioSante Pharmaceuticals Announces Reverse Stock Split in Order to Maintain NASDAQ Listing - Benzinga
- Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon - TheStreet.com
Latest Partner Headlines
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com
Separating the Bargains From the Busts - TheStreet.com
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com
Gap Up and Sit - TheStreet.com
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com
Windows 8 PC Sales Disappointing: Report - TheStreet.com
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Dow JonesCompany ID [INDEXDJX:.DJI] Last trade:15,354.40 Trade time:4:40PM EDT Value change:▲121.18 (0.80%)
S&P 500Company ID [INDEXSP:.INX] Last trade:1,667.47 Trade time:4:39PM EDT Value change:▲17.00 (1.03%)
NASDAQCompany ID [INDEXNASDAQ:.IXIC] Last trade:3,498.97 Trade time:5:15PM EDT Value change:▲33.73 (0.97%)
In The Wires
Professionally Designed Wedding Dresses Now Online At Tidebuy.com
DressFirst.com Is Providing Big Discounts On All Its Prom Dresses
Great Discounts On Evening Dresses Announced by AmorModa.com
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Vitamin Shoppe, Inc. To Contact The Firm
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Ventrus Biosciences, Inc. To Contact The Firm
Bruno Mars Ticket Prices Slashed at TicketProcess.com - Discounted Tickets Are Still Available With The Trusted Ticket Exchange Giant
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Delcath Systems, Inc. To Contact The Firm
The Rolling Stones Tour Tickets 2013 On Sale At TicketsTeam.com